1375 related articles for article (PubMed ID: 20439427)
1. The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version.
Zhao B; Li L; Lei Q; Guan KL
Genes Dev; 2010 May; 24(9):862-74. PubMed ID: 20439427
[TBL] [Abstract][Full Text] [Related]
2. The Hippo-YAP pathway: new connections between regulation of organ size and cancer.
Zhao B; Lei QY; Guan KL
Curr Opin Cell Biol; 2008 Dec; 20(6):638-46. PubMed ID: 18955139
[TBL] [Abstract][Full Text] [Related]
3. Structural and functional insights into the TEAD-YAP complex in the Hippo signaling pathway.
Chen L; Loh PG; Song H
Protein Cell; 2010 Dec; 1(12):1073-83. PubMed ID: 21213102
[TBL] [Abstract][Full Text] [Related]
4. A role for Hipk in the Hippo pathway.
Heidary Arash E; Attisano L
Sci Signal; 2013 May; 6(275):pe18. PubMed ID: 23674821
[TBL] [Abstract][Full Text] [Related]
5. Reciprocal regulation of YAP/TAZ by the Hippo pathway and the Small GTPase pathway.
Jang JW; Kim MK; Bae SC
Small GTPases; 2020 Jul; 11(4):280-288. PubMed ID: 29457552
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control.
Zhao B; Wei X; Li W; Udan RS; Yang Q; Kim J; Xie J; Ikenoue T; Yu J; Li L; Zheng P; Ye K; Chinnaiyan A; Halder G; Lai ZC; Guan KL
Genes Dev; 2007 Nov; 21(21):2747-61. PubMed ID: 17974916
[TBL] [Abstract][Full Text] [Related]
7. Disease implications of the Hippo/YAP pathway.
Plouffe SW; Hong AW; Guan KL
Trends Mol Med; 2015 Apr; 21(4):212-22. PubMed ID: 25702974
[TBL] [Abstract][Full Text] [Related]
8. The regulation and function of YAP transcription co-activator.
Zhu C; Li L; Zhao B
Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):16-28. PubMed ID: 25487920
[TBL] [Abstract][Full Text] [Related]
9. E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components.
Kim NG; Koh E; Chen X; Gumbiner BM
Proc Natl Acad Sci U S A; 2011 Jul; 108(29):11930-5. PubMed ID: 21730131
[TBL] [Abstract][Full Text] [Related]
10. Snapshots of a hybrid transcription factor in the Hippo pathway.
Luo X
Protein Cell; 2010 Sep; 1(9):811-9. PubMed ID: 21203923
[TBL] [Abstract][Full Text] [Related]
11. YAP/TAZ for cancer therapy: opportunities and challenges (review).
Guo L; Teng L
Int J Oncol; 2015 Apr; 46(4):1444-52. PubMed ID: 25652178
[TBL] [Abstract][Full Text] [Related]
12. Establishment of transgenic lines to monitor and manipulate Yap/Taz-Tead activity in zebrafish reveals both evolutionarily conserved and divergent functions of the Hippo pathway.
Miesfeld JB; Link BA
Mech Dev; 2014 Aug; 133():177-88. PubMed ID: 24560909
[TBL] [Abstract][Full Text] [Related]
13. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
[TBL] [Abstract][Full Text] [Related]
14. Opposing transcriptional and post-transcriptional roles for Scalloped in binary Hippo-dependent neural fate decisions.
Xie B; Morton DB; Cook TA
Dev Biol; 2019 Nov; 455(1):51-59. PubMed ID: 31265830
[TBL] [Abstract][Full Text] [Related]
15. Brahma regulates the Hippo pathway activity through forming complex with Yki-Sd and regulating the transcription of Crumbs.
Zhu Y; Li D; Wang Y; Pei C; Liu S; Zhang L; Yuan Z; Zhang P
Cell Signal; 2015 Mar; 27(3):606-13. PubMed ID: 25496831
[TBL] [Abstract][Full Text] [Related]
16. YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway.
Zhang J; Ji JY; Yu M; Overholtzer M; Smolen GA; Wang R; Brugge JS; Dyson NJ; Haber DA
Nat Cell Biol; 2009 Dec; 11(12):1444-50. PubMed ID: 19935651
[TBL] [Abstract][Full Text] [Related]
17. Elucidation of a universal size-control mechanism in Drosophila and mammals.
Dong J; Feldmann G; Huang J; Wu S; Zhang N; Comerford SA; Gayyed MF; Anders RA; Maitra A; Pan D
Cell; 2007 Sep; 130(6):1120-33. PubMed ID: 17889654
[TBL] [Abstract][Full Text] [Related]
18. Mask is required for the activity of the Hippo pathway effector Yki/YAP.
Sansores-Garcia L; Atkins M; Moya IM; Shahmoradgoli M; Tao C; Mills GB; Halder G
Curr Biol; 2013 Feb; 23(3):229-35. PubMed ID: 23333314
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation.
Yu FX; Zhang Y; Park HW; Jewell JL; Chen Q; Deng Y; Pan D; Taylor SS; Lai ZC; Guan KL
Genes Dev; 2013 Jun; 27(11):1223-32. PubMed ID: 23752589
[TBL] [Abstract][Full Text] [Related]
20. CDK7 regulates organ size and tumor growth by safeguarding the Hippo pathway effector Yki/Yap/Taz in the nucleus.
Cho YS; Li S; Wang X; Zhu J; Zhuo S; Han Y; Yue T; Yang Y; Jiang J
Genes Dev; 2020 Jan; 34(1-2):53-71. PubMed ID: 31857346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
